Masatoshi Nishimoto, Miho Murashima, Maiko Kokubu, Masaru Matsui, Masahiro Eriguchi, Ken-Ichi Samejima, Yasuhiro Akai, Kazuhiko Tsuruya. The use of anti-adrenergic agents as a predictor of acute kidney injury and delayed recovery of kidney function: the NARA-AKI cohort study. Hypertension research : official journal of the Japanese Society of Hypertension. 2023
Masatoshi Nishimoto, Miho Murashima, Maiko Kokubu, Masaru Matsui, Masahiro Eriguchi, Ken-Ichi Samejima, Yasuhiro Akai, Kazuhiko Tsuruya. Kidney function at 3 months after acute kidney injury is an unreliable indicator of subsequent kidney dysfunction: the NARA-AKI Cohort Study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2023. 38. 3. 664-670
Kaori Tanabe, Ken-Ichi Samejima, Fumihiro Fukata, Takaaki Kosugi, Hideo Tsushima, Katsuhiko Morimoto, Keisuke Okamoto, Masaru Matsui, Masahiro Eriguchi, Naoki Maruyama, et al. Correction to: Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease. Clinical and experimental nephrology. 2022. 26. 4. 378-378
Kaori Tanabe, Ken-Ichi Samejima, Fumihiro Fukata, Takaaki Kosugi, Hideo Tsushima, Katsuhiko Morimoto, Keisuke Okamoto, Masaru Matsui, Masahiro Eriguchi, Naoki Maruyama, et al. Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease. Clinical and experimental nephrology. 2022. 26. 1. 29-35
Shinichiro Kubo, Tatsuya Noda, Tomoya Myojin, Yuichi Nishioka, Saho Kanno, Tsuneyuki Higashino, Masatoshi Nishimoto, Masahiro Eriguchi, Kenichi Samejima, Kazuhiko Tsuruya, et al. Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deaths. Clinical and Experimental Nephrology. 2022
